Just a moment...

Report
FeedbackReport
×

By creating an account you can:

Logo TaxTMI
>
Feedback/Report an Error
Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

Remedium Lifecare Announces INR 49.19 Cr Rights Issue for Expansion

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....emedium Lifecare Announces INR 49.19 Cr Rights Issue for Expansion<BR>PTI News<BR>Dated:- 9-4-2025<BR>PTI<BR>Mumbai (Maharashtra) [India], April 9: Remedium Lifecare Limited (BSE: 539561),a fast-growing manufacturer of pharmaceutical intermediates and specialty chemicals, is pleased to announce that it has received approval from the Bombay Stock Exchange (BSE) for its proposed rights issue. The ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....approval paves the way for the company to raise growth capital from its existing shareholders, further strengthening its financial foundation and supporting its strategic initiatives, including manufacturing expansion, product development, and global market penetration. Key Highlights of the Rights Issue (as approved): • Record Date: Tuesday, April 15, 2025 • Issue Size: ?4,919.04 Lakhs (Ass....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....uming Full Subscription) • Price per Share: ?1.00 per Equity Share • Total Number of Shares: 49,19,04,000 fully paid-up equity shares of face value ?1/- each • Rights Ratio: 61 Rights Equity Shares for every 50 fully paid-up equity shares held as on the Record Date • Instrument: Fully paid-up equity shares having a face value of ?1/- each • Purpose: Working capital Requirements, Equipmen....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....t for R&D and expansion “This approval from the BSE marks a significant milestone in our journey. We remain committed to enhancing shareholder value while scaling up our operations responsibly and sustainably,” said Adarsh Munjal , Whole Time Director, Remedium Lifecare Ltd. The rights issue comes at a time when Remedium Lifecare is gaining strong traction in international markets. In Februa....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ry 2025, the company secured a multi-year export contract worth ?182.7 crore with a leading UK-based pharmaceutical distributor. The company is well- positioned to capitalize on rising global demand in key therapeutic segments such as anti- infectives, cardiovascular, CNS, and oncology-supportive drugs. About Remedium Lifecare: Founded in 1988, Remedium Lifecare Ltd. is a BSE-listed pharmaceutic....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....al company engaged in the supply of Active Pharmaceutical Ingredient (API) intermediates and specialty chemicals. With an emphasis on quality, compliance, and global reach, the company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem. (Disclaimer: The above press release comes to you under an arrangement with PNN and PTI takes no editorial respo....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....nsibility for the same.). PTI PWR PWR<BR> News - Press release - PIB....